This company has good product but has long duration trials. To sustain that - they will need to raise funds - without nasdaq - they will have to toxic financing - which means manipulation of SP (look at CTI_) This will lead to availability of shares at lower price.
Wait for the SH meeting - once authorized capital is increased we will see one round of financing - that time we could see sun 0.90 price range
Market Data 
Markets 
AI
